Taisho Pharmaceutical Pabron Gold A (granules) Unlicensed Product:, Product Is Labelled To Contain Dihydrocodeine Phosphate That Is Listed On Schedule I Of The Cdsa

Taisho Pharmaceutical Pabron Gold A (Granules) is being recalled across Canada because it contains dihydrocodeine phosphate, a controlled substance listed on Schedule I of the Controlled Drugs and Substances Act, and the product is not licensed for sale in Canada. The product was distributed nationwide.

Product

Taisho Pharmaceutical Pabron Gold A (Granules)

Reason

Product safety

Classification

Class I

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2024-06-10

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/aaca3138-b9c1-4993-b9a3-5815b2f2e059